{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:10:42Z","timestamp":1789985442310,"version":"4.0.1"},"reference-count":166,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T00:00:00Z","timestamp":1523836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>An important aspect of modern medicine is its orientation to achieve more personalized pharmacological treatments. In this context, transporters involved in drug disposition have gained well-justified attention. Owing to its broad spectrum of substrate specificity, including endogenous compounds and xenobiotics, and its strategical expression in organs accounting for drug disposition, such as intestine, liver and kidney, the SLC22 family of transporters plays an important role in physiology, pharmacology and toxicology. Among these carriers are plasma membrane transporters for organic cations (OCTs) and anions (OATs) with a marked overlap in substrate specificity. These two major clades of SLC22 proteins share a similar membrane topology but differ in their degree of genetic variability. Members of the OCT subfamily are highly polymorphic, whereas OATs have a lower number of genetic variants. Regarding drug disposition, changes in the activity of these variants affect intestinal absorption and target tissue uptake, but more frequently they modify plasma levels due to enhanced or reduced clearance by the liver and secretion by the kidney. The consequences of these changes in transport-associated function markedly affect the effectiveness and toxicity of the treatment in patients carrying the mutation. In solid tumors, changes in the expression of these transporters and the existence of genetic variants substantially determine the response to anticancer drugs. Moreover, chemoresistance usually evolves in response to pharmacological and radiological treatment. Future personalized medicine will require monitoring these changes in a dynamic way to adapt the treatment to the weaknesses shown by each tumor at each stage in each patient.<\/jats:p>","DOI":"10.3390\/jpm8020014","type":"journal-article","created":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T12:40:26Z","timestamp":1523882426000},"page":"14","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition"],"prefix":"10.3390","volume":"8","author":[{"given":"Elisa","family":"Lozano","sequence":"first","affiliation":[{"name":"Experimental Hepatology and Drug Targeting (HEVEFARM), University of Salamanca, IBSAL, 37007 Salamanca, Spain"},{"name":"Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Briz","sequence":"additional","affiliation":[{"name":"Experimental Hepatology and Drug Targeting (HEVEFARM), University of Salamanca, IBSAL, 37007 Salamanca, Spain"},{"name":"Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4748-0326","authenticated-orcid":false,"given":"Rocio","family":"Macias","sequence":"additional","affiliation":[{"name":"Experimental Hepatology and Drug Targeting (HEVEFARM), University of Salamanca, IBSAL, 37007 Salamanca, Spain"},{"name":"Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Serrano","sequence":"additional","affiliation":[{"name":"Experimental Hepatology and Drug Targeting (HEVEFARM), University of Salamanca, IBSAL, 37007 Salamanca, Spain"},{"name":"Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1186-6849","authenticated-orcid":false,"given":"Jose J. G.","family":"Marin","sequence":"additional","affiliation":[{"name":"Experimental Hepatology and Drug Targeting (HEVEFARM), University of Salamanca, IBSAL, 37007 Salamanca, Spain"},{"name":"Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Herraez","sequence":"additional","affiliation":[{"name":"Experimental Hepatology and Drug Targeting (HEVEFARM), University of Salamanca, IBSAL, 37007 Salamanca, Spain"},{"name":"Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,4,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1146\/annurev-pharmtox-010617-052713","article-title":"The SLC22 transporter family: A paradigm for the impact of drug transporters on metabolic pathways, signaling, and disease","volume":"58","author":"Nigam","year":"2018","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00424-003-1089-9","article-title":"The SLC22 drug transporter family","volume":"447","author":"Koepsell","year":"2004","journal-title":"Pflugers Arch."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Zhu, C., Nigam, K.B., Date, R.C., Bush, K.T., Springer, S.A., Saier, M.H., Wu, W., and Nigam, S.K. (2015). Evolutionary analysis and classification of OATs, OCTs, OCTNs, and other SLC22 transporters: Structure-function implications and analysis of sequence motifs. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0140569"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"23841","DOI":"10.1074\/jbc.M703467200","article-title":"Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members","volume":"282","author":"Kaler","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1124\/dmd.115.066647","article-title":"Rapid method to determine intracellular drug concentrations in cellular uptake assays: Application to metformin in organic cation transporter 1-transfected human embryonic kidney 293 cells","volume":"44","author":"Chien","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10254-002-0003-8","article-title":"Transport of organic anions across the basolateral membrane of proximal tubule cells","volume":"146","author":"Burckhardt","year":"2003","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1289\/ehp.1204951","article-title":"Polymorphisms in genes encoding potential mercury transporters and urine mercury concentrations in populations exposed to mercury vapor from gold mining","volume":"121","author":"Engstrom","year":"2013","journal-title":"Environ. Health Perspect."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/ajh.2010.191","article-title":"Association of intergenic polymorphism of organic anion transporter 1 and 3 genes with hypertension and blood pressure response to hydrochlorothiazide","volume":"24","author":"Han","year":"2011","journal-title":"Am. J. Hypertens."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/j.1523-1755.2005.00612.x","article-title":"Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)]","volume":"68","author":"Xu","year":"2005","journal-title":"Kidney Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/tpj.2015.78","article-title":"Role of SLC22A1 polymorphic variants in drug disposition, therapeutic responses, and drug-drug interactions","volume":"15","author":"Koepsell","year":"2015","journal-title":"Pharmacogenomics J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.tips.2004.05.005","article-title":"Polyspecific organic cation transporters: Their functions and interactions with drugs","volume":"25","author":"Koepsell","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1021\/mp400024d","article-title":"Polyamine transport by the polyspecific organic cation transporters OCT1, OCT2, and OCT3","volume":"10","author":"Li","year":"2013","journal-title":"Mol. Pharm."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejphar.2012.02.028","article-title":"Thiamine is a substrate of organic cation transporters in Caco-2 cells","volume":"682","author":"Lemos","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1089\/dna.1997.16.871","article-title":"Cloning and characterization of two human polyspecific organic cation transporters","volume":"16","author":"Gorboulev","year":"1997","journal-title":"DNA Cell Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s11095-007-9254-z","article-title":"Polyspecific organic cation transporters: Structure, function, physiological roles, and biopharmaceutical implications","volume":"24","author":"Koepsell","year":"2007","journal-title":"Pharm. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1124\/jpet.301.1.293","article-title":"Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins","volume":"301","author":"Kimura","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1681\/ASN.V134866","article-title":"Gene expression levels and immunolocalization of organic ion transporters in the human kidney","volume":"13","author":"Motohashi","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/mol.54.2.342","article-title":"Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine","volume":"54","author":"Busch","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1165\/rcmb.2004-0363OC","article-title":"Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium","volume":"33","author":"Lips","year":"2005","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"F449","DOI":"10.1152\/ajprenal.2000.279.3.F449","article-title":"Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney","volume":"279","author":"Wu","year":"2000","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1124\/jpet.105.086827","article-title":"Functional analysis of organic cation transporter 3 expressed in human placenta","volume":"315","author":"Sata","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"27055","DOI":"10.1074\/jbc.M114.570564","article-title":"Taste of a pill: Organic cation transporter-3 (OCT3) mediates metformin accumulation and secretion in salivary glands","volume":"289","author":"Lee","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mce.2016.12.024","article-title":"High expression of organic cation transporter 3 in human bat-like adipocytes. Implications for extraneuronal norepinephrine uptake","volume":"443","author":"Breining","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-5793(97)01441-5","article-title":"Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1","volume":"419","author":"Tamai","year":"1997","journal-title":"FEBS Lett."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1167\/iovs.07-1528","article-title":"Expression and localization of carnitine\/organic cation transporter OCTN1 and OCTN2 in ocular epithelium","volume":"49","author":"Garrett","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1073\/pnas.0408624102","article-title":"Discovery of the ergothioneine transporter","volume":"102","author":"Grundemann","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.bbamem.2011.12.014","article-title":"The human OCTN1 (SLC22A4) reconstituted in liposomes catalyzes acetylcholine transport which is defective in the mutant L503F associated to the Crohn\u2019s disease","volume":"1818","author":"Pochini","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.bbrc.2006.05.026","article-title":"Novel localization of OCTN1, an organic cation\/carnitine transporter, to mammalian mitochondria","volume":"345","author":"Lamhonwah","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"20378","DOI":"10.1074\/jbc.273.32.20378","article-title":"Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2","volume":"273","author":"Tamai","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0022-3565(24)35056-6","article-title":"Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation\/carnitine transporter","volume":"290","author":"Wu","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0006-291X(02)02946-7","article-title":"A third human carnitine\/organic cation transporter (OCTN3) as a candidate for the 5q31 Crohn\u2019s disease locus (IBD5)","volume":"301","author":"Lamhonwah","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.bbrc.2005.10.170","article-title":"OCTN3 is a mammalian peroxisomal membrane carnitine transporter","volume":"338","author":"Lamhonwah","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/S0301-472X(02)00901-3","article-title":"Identification of OCT6 as a novel organic cation transporter preferentially expressed in hematopoietic cells and leukemias","volume":"30","author":"Gong","year":"2002","journal-title":"Exp. Hematol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1124\/jpet.102.034140","article-title":"Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin","volume":"302","author":"Wang","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1124\/dmd.108.020826","article-title":"Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infection","volume":"36","author":"Jung","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/clpt.2011.56","article-title":"Genetically polymorphic OCT1: Another piece in the puzzle of the variable pharmacokinetics and pharmacodynamics of the opioidergic drug tramadol","volume":"90","author":"Tzvetkov","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/cpt.317","article-title":"OCT1 mediates hepatic uptake of sumatriptan and loss-of-function oct1 polymorphisms affect sumatriptan pharmacokinetics","volume":"99","author":"Matthaei","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/tpj.2010.75","article-title":"Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT(3) antagonists tropisetron and ondansetron","volume":"12","author":"Tzvetkov","year":"2012","journal-title":"Pharmacogenomics J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bcp.2013.06.019","article-title":"Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration","volume":"86","author":"Tzvetkov","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1124\/jpet.105.091223","article-title":"Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3)","volume":"315","author":"Bourdet","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1080\/00498250701546012","article-title":"Functional involvement of organic cation transporter1 (OCT1\/Oct1) in the hepatic uptake of organic cations in humans and rats","volume":"37","author":"Umehara","year":"2007","journal-title":"Xenobiotica"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0022-3565(24)29357-5","article-title":"Comparison of \u201cType I\u201d and \u201cType II\u201d organic cation transport by organic cation transporters and organic anion-transporting polypeptides","volume":"298","author":"Muller","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1128\/AAC.02289-12","article-title":"Human organic cation transporters 1 (SLC22A1), 2 (SLC22A2), and 3 (SLC22A3) as disposition pathways for fluoroquinolone antimicrobials","volume":"57","author":"Mulgaonkar","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.bcp.2011.12.032","article-title":"Lamotrigine is a substrate for OCT1 in brain endothelial cells","volume":"83","author":"Dickens","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11095-004-1193-3","article-title":"Metformin transport by renal basolateral organic cation transporter hOCT2","volume":"22","author":"Kimura","year":"2005","journal-title":"Pharm. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/bdd.2104","article-title":"Multiple organic cation transporters contribute to the renal transport of sulpiride","volume":"38","author":"Li","year":"2017","journal-title":"Biopharm. Drug Dispos."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s12936-017-2062-y","article-title":"Proguanil and cycloguanil are organic cation transporter and multidrug and toxin extrusion substrates","volume":"16","author":"Bilos","year":"2017","journal-title":"Malar. J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1128\/AAC.00986-16","article-title":"Multiple drug transporters are involved in renal secretion of entecavir","volume":"60","author":"Yang","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1124\/dmd.115.066175","article-title":"Atenolol renal secretion is mediated by human organic cation transporter 2 and multidrug and toxin extrusion proteins","volume":"43","author":"Yin","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/dmd.109.028142","article-title":"Characterization of human organic cation transporter 1 (OCT1\/SLC22A1)- and oct2 (SLC22A2)-mediated transport of 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazolium bromide (YM155 monobromide), a novel small molecule survivin suppressant","volume":"38","author":"Minematsu","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1517\/17425255.2012.674512","article-title":"Fluoroquinolone disposition: Identification of the contribution of renal secretory and reabsorptive drug transporters","volume":"8","author":"Mulgaonkar","year":"2012","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1124\/mol.114.096776","article-title":"Targeted disruption of organic cation transporter 3 attenuates the pharmacologic response to metformin","volume":"88","author":"Chen","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1002\/jps.23727","article-title":"The inhibitory effects of the bioactive components isolated from Scutellaria baicalensis on the cellular uptake mediated by the essential solute carrier transporters","volume":"102","author":"Xu","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/039463201202500227","article-title":"Salbutamol: How does it enter smooth muscle cells?","volume":"25","author":"Chiappori","year":"2012","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/sj.clpt.6100271","article-title":"Effects of genetic variation in the novel organic cation transporter, OCTN1, on the renal clearance of gabapentin","volume":"83","author":"Urban","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3892\/br.2016.772","article-title":"Organic cation transporter 6 directly confers resistance to anticancer platinum drugs","volume":"5","author":"Oguri","year":"2016","journal-title":"Biomed. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1046\/j.1469-1809.2000.6430267.x","article-title":"Molecular cloning, functional characterization and genomic organization of four alternatively spliced isoforms of the human organic cation transporter 1 (hOCT1\/SLC22A1)","volume":"63","author":"Hayer","year":"1999","journal-title":"Ann. Hum. Genet."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1172\/JCI30558","article-title":"Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action","volume":"117","author":"Shu","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/tpj.2009.15","article-title":"Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus","volume":"9","author":"Becker","year":"2009","journal-title":"Pharmacogenomics J."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/FPC.0b013e3283561666","article-title":"Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients","volume":"22","author":"Tarasova","year":"2012","journal-title":"Pharmacogenetics Genom."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2217\/pgs.14.99","article-title":"ABCC3 and OCT1 genotypes influence pharmacokinetics of morphine in children","volume":"15","author":"Venkatasubramanian","year":"2014","journal-title":"Pharmacogenomics"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2217\/pgs.13.94","article-title":"OCT1 genetic variants influence the pharmacokinetics of morphine in children","volume":"14","author":"Fukuda","year":"2013","journal-title":"Pharmacogenomics"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10048-010-0254-5","article-title":"OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug users","volume":"12","author":"Becker","year":"2011","journal-title":"Neurogenetics"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s002100000335","article-title":"Apical uptake of organic cations by human intestinal Caco-2 cells: Putative involvement of ASF transporters","volume":"363","author":"Martel","year":"2001","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.eplepsyres.2016.09.004","article-title":"Specific OCT1 and ABCG2 polymorphisms are associated with lamotrigine concentrations in Chinese patients with epilepsy","volume":"127","author":"Shen","year":"2016","journal-title":"Epilepsy Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1208\/s12248-014-9649-9","article-title":"The poorly membrane permeable antipsychotic drugs amisulpride and sulpiride are substrates of the organic cation transporters from the SLC22 family","volume":"16","author":"Tadjerpisheh","year":"2014","journal-title":"AAPS J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/bdd.1783","article-title":"Genetic variants of organic cation transporter 1 (OCT1) and OCT2 significantly reduce lamivudine uptake","volume":"33","author":"Choi","year":"2012","journal-title":"Biopharm. Drug Dispos."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.bcp.2012.01.032","article-title":"The prototypic pharmacogenetic drug debrisoquine is a substrate of the genetically polymorphic organic cation transporter OCT1","volume":"83","author":"Saadatmand","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/clpt.2008.61","article-title":"Genetic variants of the organic cation transporter 2 influence the disposition of metformin","volume":"84","author":"Song","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1097\/01.ASN.0000019413.78751.46","article-title":"cDNA cloning, functional characterization, and tissue distribution of an alternatively spliced variant of organic cation transporter hOCT2 predominantly expressed in the human kidney","volume":"13","author":"Urakami","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1254\/jphs.09331SC","article-title":"Functional analysis of human organic cation transporter OCT3 (SLC22A3) polymorphisms","volume":"113","author":"Sakata","year":"2010","journal-title":"J. Pharmacol. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1002\/jps.20190","article-title":"Functional characterization of human organic cation transporter OCTN1 single nucleotide polymorphisms in the Japanese population","volume":"93","author":"Kawasaki","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/FPC.0b013e3281c6d08e.","article-title":"Functional effects of protein sequence polymorphisms in the organic cation\/ergothioneine transporter OCTN1 (SLC22A4)","volume":"17","author":"Urban","year":"2007","journal-title":"Pharmacogenetics Genom."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1021\/mp400193r","article-title":"Functional analysis of novel variants in the organic cation\/ergothioneine transporter 1 identified in Singapore populations","volume":"10","author":"Toh","year":"2013","journal-title":"Mol. Pharm."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.addr.2016.06.004","article-title":"Recent advance in the pharmacogenomics of human solute carrier transporters (SLCS) in drug disposition","volume":"116","author":"Zhou","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.mam.2012.10.010","article-title":"The SLC22 family with transporters of organic cations, anions and zwitterions","volume":"34","author":"Koepsell","year":"2013","journal-title":"Mol. Aspects Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1152\/physrev.00025.2013","article-title":"The organic anion transporter (OAT) family: A systems biology perspective","volume":"95","author":"Nigam","year":"2015","journal-title":"Physiol. Rev."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Burckhardt, G., and Burckhardt, B.C. (2011). In vitro and in vivo evidence of the importance of organic anion transporters (OATS) in drug therapy. Handbook of Experimental Pharmacology, Springer.","DOI":"10.1007\/978-3-642-14541-4_2"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1124\/dmd.107.014902","article-title":"Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines","volume":"35","author":"Hilgendorf","year":"2007","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1124\/dmd.115.065250","article-title":"Shared ligands between organic anion transporters (OAT1 and OAT6) and odorant receptors","volume":"43","author":"Wu","year":"2015","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.bcp.2005.06.024","article-title":"Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1","volume":"70","author":"Ueo","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1124\/dmd.107.017459","article-title":"Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensinII AT1-receptor","volume":"35","author":"Yamada","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1124\/jpet.103.059139","article-title":"Interactions of human organic anion transporters with diuretics","volume":"308","author":"Hasannejad","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1124\/mol.56.3.570","article-title":"The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1","volume":"56","author":"Cihlar","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1124\/dmd.111.042036","article-title":"Expression of organic anion transporter 2 in the human kidney and its potential role in the tubular secretion of guanine-containing antiviral drugs","volume":"40","author":"Cheng","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1124\/jpet.105.084301","article-title":"Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6)","volume":"314","author":"Bleasby","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(02)01306-7","article-title":"Interaction of human organic anion transporters with various cephalosporin antibiotics","volume":"438","author":"Takeda","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"F503","DOI":"10.1152\/ajprenal.00290.2002","article-title":"Transport of cimetidine by flounder and human renal organic anion transporter 1","volume":"284","author":"Burckhardt","year":"2003","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2133\/dmpk.19.369","article-title":"Methotrexate-loxoprofen interaction: Involvement of human organic anion transporters hOAT1 and hOAT3","volume":"19","author":"Uwai","year":"2004","journal-title":"Drug Metab. Pharmacokinet."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/abio.2000.4633","article-title":"Fluorescence-based assay for the interaction of small molecules with the human renal organic anion transporter 1","volume":"283","author":"Cihlar","year":"2000","journal-title":"Anal. Biochem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1124\/jpet.106.116517","article-title":"Transport of the dipeptidyl peptidase-4 inhibitor sitagliptin by human organic anion transporter 3, organic anion transporting polypeptide 4C1, and multidrug resistance P-glycoprotein","volume":"321","author":"Chu","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1124\/jpet.102.037580","article-title":"Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs","volume":"303","author":"Khamdang","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0022-3565(24)38862-7","article-title":"Nonsteroidal anti-inflammatory drugs efficiently reduce the transport and cytotoxicity of adefovir mediated by the human renal organic anion transporter 1","volume":"295","author":"Mulato","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-pharmtox-011112-140317","article-title":"Renal transporters in drug development","volume":"53","author":"Morrissey","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1517\/17425255.2.4.505","article-title":"Drug-drug interactions involving membrane transporters in the human kidney","volume":"2","author":"Li","year":"2006","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1006\/bbrc.2001.4774","article-title":"Isolation of a family of organic anion transporters from human liver and kidney","volume":"283","author":"Sun","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0014-5793(98)00585-7","article-title":"Identification of multispecific organic anion transporter 2 expressed predominantly in the liver","volume":"429","author":"Sekine","year":"1998","journal-title":"FEBS Lett."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.phrs.2014.11.002","article-title":"Interaction of human organic anion transporter 2 (OAT2) and sodium taurocholate cotransporting polypeptide (NTCP) with antineoplastic drugs","volume":"91","author":"Marada","year":"2015","journal-title":"Pharmacol. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1211\/0022357055966","article-title":"Transport mechanism and substrate specificity of human organic anion transporter 2 (hOAT2 [SLC22A7])","volume":"57","author":"Kobayashi","year":"2005","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_101","first-page":"528","article-title":"High expression of organic anion transporter 2 and organic cation transporter 2 is an independent predictor of good outcomes in patients with metastatic colorectal cancer treated with FOLFOX--based chemotherapy","volume":"4","author":"Tashiro","year":"2014","journal-title":"Am. J. Cancer Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1124\/jpet.105.088104","article-title":"A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters","volume":"315","author":"Tahara","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1124\/dmd.104.003301","article-title":"Possible involvement of organic anion transporter 2 on the interaction of theophylline with erythromycin in the human liver","volume":"33","author":"Kobayashi","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1254\/jjp.88.69","article-title":"Human organic anion transporters mediate the transport of tetracycline","volume":"88","author":"Babu","year":"2002","journal-title":"Jpn. J. Pharmacol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.pharmthera.2012.07.010","article-title":"Drug transport by organic anion transporters (OATs)","volume":"136","author":"Burckhardt","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1124\/dmd.115.066944","article-title":"Diclofenac and its ACYL glucuronide: Determination of in vivo exposure in human subjects and characterization as human drug transporter substrates in vitro","volume":"44","author":"Zhang","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1074\/jbc.M110.139949","article-title":"Analysis of three-dimensional systems for developing and mature kidneys clarifies the role of OAT1 and OAT3 in antiviral handling","volume":"286","author":"Nagle","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11095-007-9407-0","article-title":"Impaired clearance of methotrexate in organic anion transporter 3 (SLC22A8) knockout mice: A gender specific impact of reduced folates","volume":"25","author":"VanWert","year":"2008","journal-title":"Pharm. Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"F1332","DOI":"10.1152\/ajprenal.00319.2007","article-title":"Organic anion transporter 3 (Oat3\/Slc22a8) knockout mice exhibit altered clearance and distribution of penicillin G","volume":"293","author":"Vanwert","year":"2007","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejps.2014.04.004","article-title":"Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and OAT3 in humans","volume":"59","author":"Maeda","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1124\/jpet.107.125831","article-title":"The contribution of organic anion transporters OAT1 and OAT3 to the renal uptake of rosuvastatin","volume":"322","author":"Windass","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1254\/jphs.94.197","article-title":"Interactions of human- and rat-organic anion transporters with pravastatin and cimetidine","volume":"94","author":"Khamdang","year":"2004","journal-title":"J. Pharmacol. Sci."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1124\/jpet.102.034330","article-title":"Characterization of methotrexate transport and its drug interactions with human organic anion transporters","volume":"302","author":"Takeda","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1248\/bpb.b16-00970","article-title":"Inhibition of methotrexate uptake via organic anion transporters OAT1 and OAT3 by glucuronides of nonsteroidal anti-inflammatory drugs","volume":"40","author":"Iwaki","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/bdd.779","article-title":"Stereoselective inhibitory effect of flurbiprofen, ibuprofen and naproxen on human organic anion transporters hOAT1 and hOAT3","volume":"32","author":"Honjo","year":"2011","journal-title":"Biopharm. Drug Dispos."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1124\/dmd.113.055194","article-title":"Aspirin and probenecid inhibit organic anion transporter 3-mediated renal uptake of cilostazol and probenecid induces metabolism of cilostazol in the rat","volume":"42","author":"Wang","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1124\/mol.107.042853","article-title":"Organic anion transporter 3 (Oat3\/Slc22a8) interacts with carboxyfluoroquinolones, and deletion increases systemic exposure to ciprofloxacin","volume":"74","author":"Vanwert","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/00498254.2015.1081993","article-title":"Drug interaction profile of the HIV integrase inhibitor cabotegravir: Assessment from in vitro studies and a clinical investigation with midazolam","volume":"46","author":"Reese","year":"2016","journal-title":"Xenobiotica"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1021\/pr200093w","article-title":"Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (OAT1)","volume":"10","author":"Wikoff","year":"2011","journal-title":"J. Proteome Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"15789","DOI":"10.1074\/jbc.M117.796516","article-title":"The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis","volume":"292","author":"Bush","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1074\/jbc.275.6.4507","article-title":"Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta","volume":"275","author":"Cha","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1681\/ASN.2007010106","article-title":"Torasemide transport by organic anion transporters contributes to hyperuricemia","volume":"18","author":"Hagos","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1124\/jpet.105.088583","article-title":"Functional characterization of rat organic anion transporter 5 (SLC22A19) at the apical membrane of renal proximal tubules","volume":"315","author":"Anzai","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Menini, A. (2010). Odorant receptors. The Neurobiology of Olfaction, CRC Press.","DOI":"10.1201\/9781420071993"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1158\/0008-5472.CAN-15-0694","article-title":"Multikinase inhibitors induce cutaneous toxicity through OAT6-mediated uptake and MAP3K7-driven cell death","volume":"76","author":"Zimmerman","year":"2016","journal-title":"Cancer Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/hep.21596","article-title":"Novel liver-specific organic anion transporter OAT7 that operates the exchange of sulfate conjugates for short chain fatty acid butyrate","volume":"45","author":"Shin","year":"2007","journal-title":"Hepatology"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/tpj.2015.55","article-title":"Variability in hepatic expression of organic anion transporter 7\/SLC22A9, a novel pravastatin uptake transporter: Impact of genetic and regulatory factors","volume":"16","author":"Burk","year":"2016","journal-title":"Pharmacogenomics J."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"16332","DOI":"10.1074\/jbc.M800737200","article-title":"Identification of a new urate and high affinity nicotinate transporter, hOAT10 (SLC22A13)","volume":"283","author":"Bahn","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nature742","article-title":"Molecular identification of a renal urate anion exchanger that regulates blood urate levels","volume":"417","author":"Enomoto","year":"2002","journal-title":"Nature"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1440-1797.2010.01368.x","article-title":"Interactions of urate transporter URAT1 in human kidney with uricosuric drugs","volume":"16","author":"Shin","year":"2011","journal-title":"Nephrology"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"100852","DOI":"10.18632\/oncotarget.20135","article-title":"Recent advances on uric acid transporters","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/ckj\/sfw010","article-title":"Analysis of ABCG2 and other urate transporters in uric acid homeostasis in chronic kidney disease: Potential role of remote sensing and signaling","volume":"9","author":"Bhatnagar","year":"2016","journal-title":"Clin. Kidney J."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2217\/14622416.9.5.597","article-title":"Pharmacogenetics of OATP (SLC21\/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney","volume":"9","author":"Zair","year":"2008","journal-title":"Pharmacogenomics"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/01213011-200504000-00003","article-title":"Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1)","volume":"15","author":"Fujita","year":"2005","journal-title":"Pharmacogenetics Genom."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/dmd.116.072264","article-title":"Organic anion transporter 2: An enigmatic human solute carrier","volume":"45","author":"Shen","year":"2017","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1124\/mol.107.043117","article-title":"Organic anion transporter 2 (SLC22A7) is a facilitative transporter of CGMP","volume":"73","author":"Cropp","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"F905","DOI":"10.1152\/ajprenal.00272.2005","article-title":"The human organic anion transporter 3 (OAT3; SLC22A8): Genetic variation and functional genomics","volume":"290","author":"Erdman","year":"2006","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1002\/jps.23581","article-title":"Reduced renal clearance of cefotaxime in Asians with a low-frequency polymorphism of OAT3 (SLC22A8)","volume":"102","author":"Yee","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s40262-017-0506-8","article-title":"Renal drug transporters and drug interactions","volume":"56","author":"Ivanyuk","year":"2017","journal-title":"Clin. Pharmacokinet."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1476-5381.2009.00545.x","article-title":"Functional characterization of nonsynonymous single nucleotide polymorphisms in the human organic anion transporter 4 (hOAT4)","volume":"159","author":"Zhou","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2125.2006.02655.x","article-title":"Torsemide renal clearance and genetic variation in luminal and basolateral organic anion transporters","volume":"62","author":"Vormfelde","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/01.ASN.0000105320.04395.D0","article-title":"Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion","volume":"15","author":"Ichida","year":"2004","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10038-008-0288-9","article-title":"Analysis of regulatory polymorphisms in organic ion transporter genes (SLC22A) in the kidney","volume":"53","author":"Ogasawara","year":"2008","journal-title":"J. Hum. Genet."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2009.10.015","article-title":"Identification of genetic polymorphisms of human oat1 and OAT2 genes and their relationship to hOAT2 expression in human liver","volume":"411","author":"Shin","year":"2010","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.2217\/pgs.15.61","article-title":"Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in children","volume":"16","author":"Visscher","year":"2015","journal-title":"Pharmacogenomics"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.phrs.2017.03.021","article-title":"Identification of new SNPs associated with severe toxicity to capecitabine","volume":"120","author":"Pellicer","year":"2017","journal-title":"Pharmacol. Res."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2052-8426-2-15","article-title":"Role of solute carriers in response to anticancer drugs","volume":"2","author":"Li","year":"2014","journal-title":"Mol. Cell. Ther."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.mam.2012.12.007","article-title":"Solute carriers (SLCs) in cancer","volume":"34","author":"Bentz","year":"2013","journal-title":"Mol. Aspects Med."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2012.10.015","article-title":"Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable gastrointestinal stromal tumours treated with imatinib therapy","volume":"68","author":"Angelini","year":"2013","journal-title":"Pharmacol. Res."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/00008571-200211000-00002","article-title":"Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences","volume":"12","author":"Kerb","year":"2002","journal-title":"Pharmacogenetics"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/hep.26425","article-title":"Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib","volume":"58","author":"Herraez","year":"2013","journal-title":"Hepatology"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1073\/pnas.0730858100","article-title":"Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1","volume":"100","author":"Shu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"692071","DOI":"10.1155\/2013\/692071","article-title":"Role of the plasma membrane transporter of organic cations OCT1 and its genetic variants in modern liver pharmacology","volume":"2013","author":"Lozano","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/tpj.2014.7","article-title":"The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemia","volume":"14","author":"Polillo","year":"2014","journal-title":"Pharmacogenomics J."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"88021","DOI":"10.18632\/oncotarget.21406","article-title":"The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia","volume":"8","author":"Galimberti","year":"2017","journal-title":"Oncotarget"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/tpj.2014.77","article-title":"Human organic cation transporter 1 (hOCT1) as a mediator of bendamustine uptake and cytotoxicity in chronic lymphocytic leukemia (CLL) cells","volume":"15","author":"Montraveta","year":"2015","journal-title":"Pharmacogenomics J."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Zheng, X., Liu, Y., Yu, Q., Wang, H., Tan, F., Zhu, Q., Yuan, L., Jiang, H., Zeng, S., and Yu, L. (2017). Response to comment on \u201cepigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin\u201d. Sci. Transl. Med., 9.","DOI":"10.1126\/scitranslmed.aam6298"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejca.2017.08.033","article-title":"Potential role of polymorphisms in the transporter genes ent1 and MATE1\/OCT2 in predicting TAS-102 efficacy and toxicity in patients with refractory metastatic colorectal cancer","volume":"86","author":"Suenaga","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/tpj.2011.60","article-title":"Genetic and epigenetic regulation of the organic cation transporter 3, SLC22A3","volume":"13","author":"Chen","year":"2013","journal-title":"Pharmacogenomics J."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/gut.2010.215947","article-title":"Common variant in 6q26-q27 is associated with distal colon cancer in an Asian population","volume":"60","author":"Cui","year":"2011","journal-title":"Gut"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"11252","DOI":"10.1073\/pnas.1200853109","article-title":"Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis","volume":"109","author":"Grisanzio","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3324\/haematol.2012.066480","article-title":"Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy","volume":"98","author":"Angelini","year":"2013","journal-title":"Haematologica"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bdd.693","article-title":"Organic anion transporters: Discovery, pharmacology, regulation and roles in pathophysiology","volume":"31","author":"VanWert","year":"2010","journal-title":"Biopharm. Drug Dispos."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/00498250801927435","article-title":"Physiology, structure, and regulation of the cloned organic anion transporters","volume":"38","author":"Srimaroeng","year":"2008","journal-title":"Xenobiotica"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/B978-0-12-800223-0.00006-2","article-title":"SLC22, SLC44, and SLC47 transporters\u2014Organic anion and cation transporters: Molecular and cellular properties","volume":"73","author":"Pelis","year":"2014","journal-title":"Curr. Top. Membr."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/gm298","article-title":"DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma","volume":"3","author":"Schaeffeler","year":"2011","journal-title":"Genome Med."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/8\/2\/14\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:00:53Z","timestamp":1760194853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/8\/2\/14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,16]]},"references-count":166,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,6]]}},"alternative-id":["jpm8020014"],"URL":"https:\/\/doi.org\/10.3390\/jpm8020014","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,16]]}}}